Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,497

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,881

Class I recallsReasonable probability of serious health consequences

24,543

Class II recallsTemporary or medically reversible health consequences

2,935

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of assurance of sterility 2,098 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-all-cheddar-cheese-products-because-possible-health-riskPublished November 10, 2026

Most affected stateHawaii 200 recalls mention this state

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 11, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, a) 5 mL and b) 10 mL, JOHN HOLLIS Pharmacist, Inc 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

B-Complex/Adenosine Inj sol, Adenosine-5-Monophosphate 0.03g, Choline Chloride 0.01g, Cyanocobalamin 0.3mg, Inositol 0.05g, Methionine 0.015g, Levocarnitine 0.1g, Chromic Chloride 0.15g, Lidocaine HCl 0.01g, Pyrodoxine HCl 0.005g, 30 mL, JOHN HOLLIS Pharmacist, Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, Alprostadil 20 mcg, a) 5 mL and b) 10 mL, JOHN HOLLIS Pharmacist, Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

METHYLCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Methylcobalamin 1000 mcg, Also Contains: Benzyl Alcohol, Sodium Chloride, Water, Hydrochloric Acid, and/or Sodium Hydroxide, 30 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Levocarnitine Solution for injection, l-Carnitine 50 mg, Also Contains Sterile Water for Injection and Benzyl Alcohol pH adjusted with HCl, 50 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

MIC PLUS B12, Adenosine, L-Carnitine, Contains: Methionine 15mg, Choline 100mg, Inositol 50mg, B 12, 0.200mg, Adenosine 20mg, L-Carnitine 30mg/ML, 30ML MULTI DOSE VIAL, BENZYL ALCOHOL AS A PRESERVATIVE, JOHN HOLLIS Pharmacist, Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg, also contains: Cotton Seed Oil, Benzyl Benzoate, Benzyl Alcohol, Rx Only, 10 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Polidocanol 5% Solution for Injection, each mL contains Polidocanol (Laureth 9) 50 mg, also contains Sterile Water for Injection, Ethyl Alcohol, Anhydrous Chlorobutanol, 50 mL Vial, JOHN HOLLIS Pharmacist Inc, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

CYANOCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Each mL contains: Cyanocobalamin 1000 mcg, , Also Contains: Benzyl Alcohol, Sodium Chloride, Water, Hydrochloric Acid, and/or Sodium Hydroxide, 30 mL, JOHN HOLLIS Pharmacist Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Liver Derivative Complex for injection, each mL contains: Liver Derivative Complex 25.5mg, also contains: Water for Injection, Phenol 0.5%, HCl or NaOH to adjust pH, 10 mL, Compounded by Prescription: JOHN HOLLIS Pharmacist Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 12, 2015Historical recordClass III

Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01

by Novartis Pharmaceuticals Corp.

Reason: Failed Stability Specification; out of specification result for particle size distribution during stability testing
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 15, 2014Historical recordClass II

Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 73502 1

by Thorne Research Inc

Reason: Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 15, 2014Historical recordClass II

Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 74002 5

by Thorne Research Inc

Reason: Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Polidocanol 1% Solution for Injection, each mL contains Polidocanol (Laureth 9) 10 mg, also contains Sterile Water for Injection, Ethyl Alcohol, Anhydrous Chlorobutanol, 50 mL, JOHN HOLLIS Pharmacist, Inc. 110 B2 Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Papaverine HCl 30 mg, Phentolamine Mesylate 2 mg, Alprostadil 40 mcg, a) 5 mL and b) 10 mL, JOHN HOLLIS Pharmacist, Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Mannitol 5% Solution for injection, Mannitol 50 mg, also contains Sterile Water for Injection, Chlorobutanol USP, 50 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 2, 2014Historical recordClass II

Polidocanol 0.5% Solution for Injection, Polidocanol (Laureth 9) 5mg, 50 mL, JOHN HOLLIS Pharmacist Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

by John W Hollis Inc

Reason: Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 23, 2015Historical recordClass II

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

by Actavis Inc

Reason: Subpotent Drug.
Published: June 25, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 22, 2016Historical recordClass I

CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.

by Cubist Pharmaceuticals, Inc.

Reason: Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.
Published: June 18, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 1, 2015Historical recordClass II

Dr. Reddy's Metoprolol Succinate Extended Release Tablets, USP 25 mg. 100-count bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories Limited, Batchupally - 500 090 India. NDC55111-466-01

by Dr. Reddy's Laboratories, Inc.

Reason: Failed Dissolution Specifications: Failure of dissolution test observed at the 18 month time point.
Published: June 18, 2014
Distribution: Nationwide

View recall →

Data last updated: November 11, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.